48 / 48
Dynarb 150 mg.
Each tablet contains 150 mg
irbesartan.Reg.No.:RSA S3 43/7.1.3/0720.NAM NS2 12/7.1.3/0223.
Dynarb 300 mg.
Each tablet contains 300 mg
irbesartan.Reg.No.:RSA S3 43/7.1.3/0721.NAM NS2 12/7.1.3/0224.
For full prescribing information, refer to the package insert approved by the Medicines Control Council, 15 Nov 2011.
1)
Kintscher U, et al. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: A sub
analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients. Cardiovasc Diabetol. 2007 Apr 3;6:12.
2)
Rayner B. A post-authorisation study of irbesartan-based therapy in
private practice in South Africa – The Active Study. SA Cardiology & Stroke. Summer 2007:46-50.
3)
Prices as per Department of Health website.
http:
/www.mpr.gov.za/– Accessed 02/07/2015.
DBA122/07/2015
For further product information contact
PHARMA DYNAMICS
P O Box 30958 Tokai Cape Town 7966
Tel
021 707 7000
Fax
021 701 5898
CUSTOMER CARE LINE
0860 PHARMA (742 762)
www.pharmadynamics.co.za